The Influence of Co-Morbidity and Frailty on the Clinical Manifestation of Patients with Alzheimer's Disease

Article type: Research Article

Authors: Oosterveld, Saskia M.^{a; *} | Kessels, Roy P.C.^{a; b; c} | Hamel, Renske^d | Ramakers, Inez H.G.B.^d | Aalten, Pauline^d | Verhey, Frans R.J.^d | Sistermans, Nicole^e | Smits, Lieke L.^e | Pijnenburg, Yolande A.^e | van der Flier, Wiesje M.^{e; f} | Olde Rikkert, Marcel G.M.^a | Melis, René J.F.^a

Affiliations: [a] Department of Geriatrics & Radboud Alzheimer Center, Radboud University Medical Center, Nijmegen, The Netherlands | [b] Department of Medical Psychology, Radboud University Medical Center, Nijmegen, The Netherlands | [c] Donders Institute for Brain, Cognition and Behavior, Radboud University Nijmegen, The Netherlands | [d] Department of Psychiatry and Neuropsychology, Maastricht University, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht, The Netherlands | [e] Alzheimer Center & Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands | [f] Department of Epidemiology & Biostatistics, VU University Medical Center, Amsterdam, The Netherlands

Correspondence: [*] Correspondence to: Saskia M. Oosterveld, Radboud University Medical Center, Department of Geriatric Medicine 925, PO Box 9101, NL-6500 HB, Nijmegen, The Netherlands. Tel.: +31 24 3616772; Fax: +31 24 3617408; E-mail: [email protected].

Abstract: Co-morbidity and frailty are common in Alzheimer's disease (AD) and may contribute to the heterogeneity in clinical manifestations of the disease. We cross-sectionally investigated whether co-morbidity and frailty were independently associated with the clinical manifestation of AD in the 4C–Dementia study; a multicenter, longitudinal study in newly diagnosed AD patients. Clinical manifestation was operationalized using a composite of cognitive performance (neuropsychological assessment), activities of daily living (Disability Assessment for Dementia; DAD) and neuropsychiatric symptoms (Neuropsychiatric Inventory). As predictors of prime interest, co-morbidity was determined using the Cumulative Illness Rating Scale (CIRS-G) and frailty by the Fried criteria. In total, 213 AD patients participated (mean age 75 ± 10 years; 58% females). In linear regression models adjusted for age, gender, education, and disease duration, CIRS-G (β = −0.21, p < 0.01) and frailty (β = −0.34, p < 0.001) were separately associated with clinical AD manifestation. However, CIRS-G (β = −0.12, p = 0.12) lost statistical significance when both were combined (frailty: β = −0.31, p < 0.001). Models with the individual components of clinical AD manifestation as dependent variables show significant associations between cognitive performance and CIRS-G (β = −0.22, p = 0.01), and between DAD and frailty (β = −0.37, p < 0.001). Our findings indicate that physical health and clinical AD manifestation are associated. This association may be responsible for part of the heterogeneity in the presentation of AD. This emphasizes the importance of adequate assessment of co-morbid medical conditions and frailty in patients with AD.

Keywords: Activities of daily living, Alzheimer's disease, co-morbidity, cognitive performance, dementia, frailty

DOI: 10.3233/JAD-140138

Journal: Journal of Alzheimer's Disease, vol. 42, no. 2, pp. 501-509, 2014